Eva
Pérez Pampín
Hospital General Universitario de Alicante
Alicante, EspañaPublications in collaboration with researchers from Hospital General Universitario de Alicante (7)
2020
-
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice
Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 112-119
2019
-
Objectives and methodology of BIOBADASER phase III
Reumatologia Clinica, Vol. 15, Núm. 4, pp. 229-236
-
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135
2017
-
Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis
Arthritis Care and Research, Vol. 69, Núm. 1, pp. 150-155
2016
-
Centre-related variability in hospital admissions of patients with spondyloarthritis
Rheumatology International, Vol. 36, Núm. 9, pp. 1301-1308
2015
-
Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients
Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 717-723
2008
-
Reacciones adversas relacionadas con la administración de inhibidores del TNF. Análisis de un registro de terapias biológicas
Reumatologia Clinica, Vol. 4, Núm. 3, pp. 90-95